2018 AANS Annual Scientific Meeting-596. Early VTE Chemoprophylaxis in TBI Patients Is Safe and Effective

596. Early VTE Chemoprophylaxis in TBI Patients Is Safe and Effective

Video Transcription

Video Summary

Dr. David Shin, a PGY3 at the University of Florida, discusses his research on early venous thromboembolism (VTE) prophylaxis in traumatic brain injury (TBI) patients. He notes that TBI patients are at increased risk of developing VTE due to immobility and brain injury. Current guidelines recommend the use of low molecular weight heparin or low dose unfractionated heparin in combination with mechanical prophylaxis, but there is no strong evidence to support this recommendation. Dr. Shin's study retrospectively reviewed 521 TBI patients and found that early administration of chemoprophylaxis did not result in worsening intracranial hemorrhage, and significantly reduced the incidence of DVT and/or PE. However, there were limitations to the study, including its retrospective nature and imbalance in patient groups. Overall, the study suggests that early chemoprophylaxis may be safe and effective in reducing thromboembolic events in TBI patients. No credits are mentioned.

Asset Caption

David Heegwang Shin, MD

Keywords

Dr. David Shin

early venous thromboembolism prophylaxis

traumatic brain injury patients

chemoprophylaxis

thromboembolic events